+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Biopharmaceutical contract manufacturing Market Size, Outlook and Growth Opportunities, 2019- 2025

  • ID: 4858993
  • Report
  • November 2019
  • Region: Global
  • 130 pages
  • OG Analysis
1 of 4

FEATURED COMPANIES

  • AGC Biologics
  • Boehringer Ingelheim GmbH
  • Inno Biologics Sdn Bhd
  • JRS PHARMA
  • Lonza
  • ProBioGen
  • MORE
Global Biopharmaceutical contract manufacturing Market Size, Outlook and Growth Opportunities to 2025: By Contract Type (Active Pharmaceutical Ingredient, Fill-And-Finish), By Product Type (Interferons, Monoclonal Antibodies, Recombinant Hormone, Proteins, Vaccines, Vitamins, Insulin, and Others), By Application (Oncology, Autoimmune Diseases, Metabolic diseases, cardiovascular diseases, Neurology, Infectious diseases, and others) and By Region

The 'Biopharmaceutical contract manufacturing market outlook to 2025' report includes the latest predictions of the global Biopharmaceutical contract manufacturing market along with geography, therapy area, and applications. The report specifically focuses on different types of Biopharmaceutical contract manufacturing with special attention to their emergence over the forecast period to 2025.

The research report provides objective measures to tap into future opportunities that will be available over the next six-years. It also highlights key areas to watch over the future along with detailed insights into drivers and challenges across different Biopharmaceutical contract manufacturing applications and products.

The Biopharmaceutical contract manufacturing market report aggregates the current market size based on volume and average price data. It also includes a six-year outlook to 2025 based on anticipated growth rates for each sub-segment and industry as a whole.

The base case outlook in the next six-years for different types of Biopharmaceutical contract manufacturing, across different verticals and countries, is provided. It additionally examines the key dynamics around companies, markets, along with key trends, drivers and challenges facing the Biopharmaceutical contract manufacturing worldwide.

The report covers a broad region from the Asia Pacific, North America, Europe, Latin America, and Middle East Africa from 2018 to 2025. 12 countries across these regions are analyzed independently in the Biopharmaceutical contract manufacturing report. Impact of domestic market conditions, price variations, competition, government policies, healthcare spending, technological and local market conditions are assessed for country-level forecasts.

Global spending on healthcare continues to increase significantly with the aging population, increased access to treatment and ongoing advancements in technology. This provides strong support for Biopharmaceutical contract manufacturing market growth in the medium to long term future. While growth will remain steady in the developed markets, Asian and other emerging markets will be key for Biopharmaceutical contract manufacturing market growth from 2019 to 2025.

To address the expanding need for advanced Biopharmaceutical contract manufacturing products, companies are rapidly embracing the new market dynamics, primarily focusing on new launches, specifically to suit local and regional demand patterns. Accordingly, detailed discussion about broader implications of key strategies, product launches, and other latest Biopharmaceutical contract manufacturing market developments are included in the research work.

Scope of the Biopharmaceutical contract manufacturing report
This report covers the 2018 market scenario and outlook of Biopharmaceutical contract manufacturing to 2025. Market size is computed using different types, applications of Biopharmaceutical contract manufacturing across geographies.

1. Biopharmaceutical contract manufacturing market size, US$, 2018-2025
2. Biopharmaceutical contract manufacturing market drivers
3. Biopharmaceutical contract manufacturing market challenges
4. Biopharmaceutical contract manufacturing market opportunities
5. Biopharmaceutical contract manufacturing market trends
6. Biopharmaceutical contract manufacturing market size forecast by type, 2018-2025
7. Biopharmaceutical contract manufacturing market size forecast by application, 2018-2025
8. Biopharmaceutical contract manufacturing market size forecast by country, 2018-2025
9. Biopharmaceutical contract manufacturing market companies and their strategies
10. Financial and Business Profile of leading vendors
11. Biopharmaceutical contract manufacturing market news and deals

The unbiased independent analysis can save clients significant time and expense by providing an intensive evaluation of Biopharmaceutical contract manufacturing market conditions. Our intensive research and sophisticated forecast methodology ensure the reliability of market estimates. Further, one free hour of our analyst’s time can be provided upon the procurement of this market report.

The report will be delivered in two working days after order confirmation.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AGC Biologics
  • Boehringer Ingelheim GmbH
  • Inno Biologics Sdn Bhd
  • JRS PHARMA
  • Lonza
  • ProBioGen
  • MORE
1. Table of Contents
1.1. List of Tables
1.2. List of Figures

2. A Review of 2018. and Outlook to 2025
2.1. Trend Analysis
2.2. Critical Success Factors
2.3. Demand and Growth Dynamics by Type
2.4. Demand and Growth Dynamics by Application
2.5. Demand and Growth Dynamics by Market

3. Strategic Analysis
3.1. Largest Drivers of Biopharmaceutical contract manufacturing Market Growth
3.2. Different Challenges Faced by Biopharmaceutical contract manufacturing Companies
3.3. Five Forces Analysis

4. Biopharmaceutical contract manufacturing Market, by Contract Type
4.1 Active Pharmaceutical Ingredient
4.2 Fill-And-Finish

5. Biopharmaceutical contract manufacturing Market, by Product Type
5.1 Interferons
5.2 Monoclonal Antibodies
5.3 Recombinant Hormone
5.4 Proteins
5.5 Vaccines
5.6 Vitamins
5.7. Insulin
5.8. Others

6. Biopharmaceutical contract manufacturing Market, by Application
6.1 Oncology
6.2 Autoimmune Diseases
6.3 Metabolic dieseases
6.4 Cardiovascular dieseases
6.5 Neurology
6.6 Infectious dieseases
6.7. others

7. Asia Pacific Biopharmaceutical contract manufacturing Market Outlook
7.1 Leading Biopharmaceutical contract manufacturing Types contributing to Asia Pacific market
7.2 Top Applications contributing to Asia Pacific Biopharmaceutical contract manufacturing
7.3 Top countries contributing to Asia Pacific Biopharmaceutical contract manufacturing

8. Europe Biopharmaceutical contract manufacturing Market Outlook
8.1 Leading Biopharmaceutical contract manufacturing Types contributing to Europe market
8.2 Top Applications contributing to Europe Biopharmaceutical contract manufacturing
8.3 Top countries contributing to Europe Biopharmaceutical contract manufacturing

9. North America Biopharmaceutical contract manufacturing Market Outlook
9.1 Leading Biopharmaceutical contract manufacturing Types contributing to North America market
9.2 Top Applications contributing to North America Biopharmaceutical contract manufacturing
9.3 Top countries contributing to North America Biopharmaceutical contract manufacturing

10 South and Central America Biopharmaceutical contract manufacturing Market Outlook
10.1 Leading Biopharmaceutical contract manufacturing Types contributing to South and Central America market
10.2 Top Applications contributing to South and Central America Biopharmaceutical contract manufacturing
10.3 Top countries contributing to South and Central America Biopharmaceutical contract manufacturing

11 Middle East Africa Biopharmaceutical contract manufacturing Market Outlook
11.1 Leading Biopharmaceutical contract manufacturing Types contributing to Middle East Africa market
11.2 Top Applications contributing to Middle East Africa Biopharmaceutical contract manufacturing
11.3 Top countries contributing to Middle East Africa Biopharmaceutical contract manufacturing

12 Company Profile Snapshots
12.1 Top Companies Operating in Biopharmaceutical contract manufacturing market
12.2 AGC Biologics Business Profile, SWOT and Financial Analysis
12.3 Boehringer Ingelheim GmbH Business Profile, SWOT and Financial Analysis
12.4 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Business Profile, SWOT and Financial Analysis
12.5 Inno Biologics Sdn Bhd Business Profile, SWOT and Financial Analysis
12.6 JRS PHARMA Business Profile, SWOT and Financial Analysis
12.7. Lonza Business Profile, SWOT and Financial Analysis
12.8. ProBioGen Business Profile, SWOT and Financial Analysis
12.9. Rentschler Biotechnologie GmbH Business Profile, SWOT and Financial Analysis
12.10 Samsung BioLogics Business Profile, SWOT and Financial Analysis
12.11 TOYOBO CO., LTD. Business Profile, SWOT and Financial Analysis

13 Recent Industry Developments

14 Appendix
14.1 Author's Expertise
14.2 Sources and Methodology
14.3 Contacts
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AGC Biologics
  • Boehringer Ingelheim GmbH
  • FUJIFILM Diosynth Biotechnologies U.S.A. Inc.
  • Inno Biologics Sdn Bhd
  • JRS PHARMA
  • Lonza
  • ProBioGen
  • Rentschler Biotechnologie GmbH
  • Samsung BioLogics
  • TOYOBO CO. Ltd.
Note: Product cover images may vary from those shown
5 of 4

Loading
LOADING...

Adroll
adroll